Servais, Laurent ; Université de Liège - ULiège > Département des sciences cliniques
Dangouloff, Tamara ; Université de Liège - ULiège > Département des sciences cliniques
Muntoni, Francesco; The Dubowitz Neuromuscular Unit, UCL Great Ormond Street Institute of Child Health, NIHR Great Ormond Street Hospital Biomedical Research Centre and Great Ormond Street Hospital NHS Foundation Trust, London, UK
Scoto, Mariacristina; The Dubowitz Neuromuscular Unit, UCL Great Ormond Street Institute of Child Health, NIHR Great Ormond Street Hospital Biomedical Research Centre and Great Ormond Street Hospital NHS Foundation Trust, London, UK
Baranello, Giovanni; The Dubowitz Neuromuscular Unit, UCL Great Ormond Street Institute of Child Health, NIHR Great Ormond Street Hospital Biomedical Research Centre and Great Ormond Street Hospital NHS Foundation Trust, London, UK
Language :
English
Title :
Spinal muscular atrophy in the UK: the human toll of slow decisions.
Aragon-Gawinska, K, Mouraux, C, Dangouloff, T, Servais, L, Spinal muscular atrophy treatment in patients identified by newborn screening— a systematic review. Genes (Basel), 14, 2023, 1377.
Pera, MC, Mercuri, E, Treatment of spinal muscular atrophy. Curr Opin Pediatr 36 (2024), 612–618.
Schwartz, O, Vill, K, Pfaffenlehner, M, et al. Clinical effectiveness of newborn screening for spinal muscular atrophy: a nonrandomized controlled trial. JAMA Pediatr 178 (2024), 540–547.
Boemer, F, Caberg, JH, Beckers, P, et al. Three years pilot of spinal muscular atrophy newborn screening turned into official program in southern Belgium. Sci Rep, 11, 2021, 19922.
Dangouloff, T, Hiligsmann, M, Deconinck, N, et al. Financial cost and quality of life of patients with spinal muscular atrophy identified by symptoms or newborn screening. Dev Med Child Neurol 65 (2023), 67–77.
Kirschner, J, Bernert, G, Butoianu, N, et al. 2024 update: European consensus statement on gene therapy for spinal muscular atrophy. Eur J Paediatr Neurol 51 (2024), 73–88.
Bendor-Samuel, OM, Wishlade, T, Willis, L, et al. Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials. Arch Dis Child 108 (2023), 26–30.
Weidlich, D, Servais, L, Kausar, I, Howells, R, Bischof, M, Cost effectiveness of newborn screening for spinal muscular atrophy in England. Neurol Ther 12 (2023), 1205–1220.
Schroth, M, Deans, J, Arya, K, et al. Spinal muscular atrophy update in best practices: recommendations for diagnosis considerations. Neurol Clin Pract, 14, 2024, e200310.
